Publications

Educators

August 2018
Article

The Impact of the Entry of Biosimilars: Evidence from Europe

By: Fiona M. Scott Morton, Ariel Dora Stern and Scott Stern

Biologics represent a substantial and growing share of the U.S. drug market. Traditional “small molecule” generics quickly erode the price and share of the branded product upon entry; however, only a few biosimilars have been approved in the U.S. since 2015, thereby... View Details

Keywords: Health Care; Biosimilars; Biologics; Pharmaceutical Competition; Healthcare Spending; Innovation; Health Care and Treatment; Spending; Market Entry and Exit; Competition; Innovation and Invention; Pharmaceutical Industry; United States; Europe

Find at Harvard

Register to Read

23 Jun 2014
News

Halle Tecco: Digital Health Pioneer. Angel Investor. Social Activist.

Forthcoming
Article

Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices

By: Jason Shafrin, Jaehong Kim, Joshua T. Cohen, Louis P. Garrison, Dana A. Goldman, Jalpa A. Doshi, Joshua Krieger, Darius N. Lakdawalla, Peter J. Neumann, Charles E. Phelps, Melanie D. Whittington and Richard Willke

This study argues that value assessment conducted from a societal perspective should rely on the Generalized Cost-Effectiveness Analysis (GCEA) framework proposed herein. Recently developed value assessment inventoriessuch as the Second Panel on Cost-Effectiveness’s... View Details

Article

Overturning the ACA's Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women's Healthcare Spending and Utilization

By: Lucy Chen, Richard G. Frank and Haiden A. Huskamp

In late 2020, the Supreme Court began hearing a case challenging the Affordable Care Act (ACA), which led to coverage gains for many low-income, reproductive-age women. To explore potential implications of a full ACA repeal for this population, we examined gains... View Details

Keywords: Medicaid; Women's Health; Health Insurance; Health Care and Treatment; Gender; Insurance; Poverty; Health Industry; United States

13 Nov 2015
News

If CEOs Care About the Long Term, Why Don’t They Talk About It?

Article

Regulating Hospital Prices Based on Market Concentration Is Likely to Leave High-Price Hospitals Unaffected

By: Maximilian J. Pany, Michael E. Chernew and Leemore S. Dafny

Concern about high hospital prices for commercially insured patients has motivated several proposals to regulate these prices. Such proposals often limit regulations to highly concentrated hospital markets. Using a large sample of 2017 US commercial insurance claims,... View Details

Keywords: Health Care Providers; Hospitals; Insurance Market Regulation; Price Regulation; Markets; Health Care and Treatment; Cost; Quality; Insurance; Price; Governing Rules, Regulations, and Reforms

Find at Harvard

March 2014 (Revised September 2017)
Case

salaUno: Eliminating Needless Blindness in Mexico

By: Richard Hamermesh, Regina Garcia Cueller and Valeria Moy

In May 2013 the co-founders and co-CEOs of salaUno, Javier Okhuysen and Carlos Orellana, were encouraged by the results of their fledgling start-up. salaUno was founded as a for-profit enterprise in order to have the capital needed for rapid growth and to fulfill its... View Details

Keywords: Medical Services; Developing Countries; Developing Markets; Health Care Industry; Health Services; Healthcare Ventures; Healthcare Startups; Health Care and Treatment; Health; Business Startups; Developing Countries and Economies; Growth and Development Strategy; Health Industry; Mexico; Mexico City

Educators

August 2015 (Revised August 2015)
Case

Hoag Orthopedic Institute

By: Robert S. Kaplan and Jonathan Warsh

Two groups of orthopedic surgeons form a joint venture with a community hospital to establish Hoag Orthopedic Institute, a for-profit hospital and two ambulatory service centers. By controlling and integrating all aspects of the patients' medical treatment, the... View Details

Keywords: Outcomes Measurement; Bundled Payment; Health Care; Activity-based Costing And Management; Measurement and Metrics; Activity Based Costing and Management; Competitive Strategy; Medical Specialties; Health Care and Treatment; Outcome or Result; Health Industry

Educators

01 Nov 2006
Working Paper Summaries

Male Circumcision and AIDS: The Macroeconomic Impact of a Health Crisis

Keywords: by Eric D. Werker, Amrita Ahuja & Brian Wendell

05 Sep 2017
News

Narrow Networks On The Health Insurance Marketplaces: Prevalence, Pricing, And The Cost Of Network Breadth

04 Jun 2009
News

NEJM Explores The Value-Based System Approach To Health Reform

November–December 2015
Article

Active Postmarketing Drug Surveillance for Multiple Adverse Events

By: Joel Goh, Margrét V. Bjarnadóttir, Mohsen Bayati and Stefanos A. Zenios

Postmarketing drug surveillance is the process of monitoring the adverse events of pharmaceutical or medical devices after they are approved by the appropriate regulatory authorities. Historically, such surveillance was based on voluntary reports by medical... View Details

Keywords: Drug Surveillance; Health Care; Stochastic Models; Queueing; Diffusion Approximation; Brownian Motion; Health Care and Treatment; Analytics and Data Science; Analysis

Find at Harvard

July 24, 2024
Article

Providing Value and Equity in Medicare's Dementia Care Is a Must

By: Susanna Gallani and Lidia Moura

Keywords: Health Care and Treatment

19 Jun 2013
News

US accountable care organisations: factory-style focus calls for change in behaviour

15 Feb 2022
Blog Post

Health Is Wealth | The Path To Creating A Venture

Rachel Sanders (MBA 2017) started her professional career working in healthcare focused investment banking. After spending four years working at Raymond James focused on middle market transactions, M&A, and the intersection of... View Details

Keywords: Health Care; Health Care

Web

Investing in Emerging Industries | Baker Library | Bloomberg Center | Harvard Business School

“[requiring] the most exhaustive investigation, careful thought, and conservatively weighted appraisals.” [10] Lehman Brothers also created an investment advisory service for wealthy individuals and... View Details

02 Jan 2020
News

Medicare for All or Public Option: Can Either Heal Health Care?

May 2017
Teaching Plan

Neurotrack and the Alzheimer's Puzzle

By: Richard G. Hamermesh and Carin-Isabel Knoop

Teaching Note for HBS No. 816-072. View Details

Keywords: Health Care; Alzheimer's Disease; Career Path; Life Science Business